Litcius/Paper detail

NanoBRET binding assay for histamine H2 receptor ligands using live recombinant HEK293T cells

Lukas Grätz, Katharina Tropmann, Merlin Bresinsky, Christoph Müller, Günther Bernhardt, Steffen Pockes

2020Scientific Reports28 citationsDOIOpen Access PDF

Abstract

Abstract Fluorescence/luminescence-based techniques play an increasingly important role in the development of test systems for the characterization of future drug candidates, especially in terms of receptor binding in the field of G protein-coupled receptors (GPCRs). In this article, we present the establishment of a homogeneous live cell-based BRET binding assay for the histamine H 2 receptor with different fluorescently labeled squaramide-type compounds synthesized in the course of this study. Py-1-labeled ligand 8 (UR-KAT478) was found to be most suitable in BRET saturation binding experiments with respect to receptor affinity (p K d = 7.35) and signal intensity. Real-time kinetic experiments showed a full association of 8 within approximately 30 min and a slow dissociation of the ligand from the receptor. Investigation of reference compounds in BRET-based competition binding with 8 yielded p K i values in agreement with radioligand binding data. This study shows that the BRET binding assay is a versatile test system for the characterization of putative new ligands at the histamine H 2 receptor and represents a valuable fluorescence-based alternative to canonical binding assays.

Topics & Concepts

ReceptorHistamine receptorG protein-coupled receptorRadioligandHEK 293 cellsRadioligand AssayHistamine H4 receptorLigand binding assayChemistryLigand (biochemistry)Recombinant DNAFluorescenceHistamineBiophysicsBinding siteHistamine H1 receptorBiochemistryBiologyHistamine H2 receptorPharmacologyAntagonistGenePhysicsQuantum mechanicsReceptor Mechanisms and SignalingMast cells and histamineCircadian rhythm and melatonin